194 related articles for article (PubMed ID: 36135078)
21. Treatment regimens and survival among patients with head and neck squamous cell carcinoma from Mizo tribal population in northeast India - a single centre, retrospective cohort study.
Zami Z; Pachuau L; Bawihtlung Z; Khenglawt L; Hlupuii L; Lalthanpuii C; Hruaii V; Lalhruaitluanga H; Kumar NS
Lancet Reg Health Southeast Asia; 2024 May; 24():100377. PubMed ID: 38444884
[TBL] [Abstract][Full Text] [Related]
22. Preoperative Neutrophil-to-lymphocyte Ratio Predicts Long-term Survival in Patients Undergoing Total Laryngectomy With Advanced Laryngeal Squamous Cell Carcinoma: A Single-center Retrospective Study.
Fu Y; Liu W; OuYang D; Yang A; Zhang Q
Medicine (Baltimore); 2016 Feb; 95(6):e2689. PubMed ID: 26871799
[TBL] [Abstract][Full Text] [Related]
23. [Retrospective analysis of 760 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations].
Tao L; Zhou L; Wu HT; Li XM; Chen XL; Li C; Xie M; Zhang M; Cheng L; Tang D
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):737-744. PubMed ID: 29873209
[No Abstract] [Full Text] [Related]
24. Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Dietz A; Wichmann G; Kuhnt T; Pfreundner L; Hagen R; Scheich M; Kölbl O; Hautmann MG; Strutz J; Schreiber F; Bockmühl U; Schilling V; Feyer P; de Wit M; Maschmeyer G; Jungehülsing M; Schroeder U; Wollenberg B; Sittel C; Münter M; Lenarz T; Klussmann JP; Guntinas-Lichius O; Rudack C; Eich HT; Foerg T; Preyer S; Westhofen M; Welkoborsky HJ; Esser D; Thurnher D; Remmert S; Sudhoff H; Görner M; Bünzel J; Budach V; Held S; Knödler M; Lordick F; Wiegand S; Vogel K; Boehm A; Flentje M; Keilholz U
Ann Oncol; 2018 Oct; 29(10):2105-2114. PubMed ID: 30412221
[TBL] [Abstract][Full Text] [Related]
25. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
Zhao TC; Liang SY; Ju WT; Liu Y; Tan YR; Zhu DW; Zhang CP; Zhang ZY; Zhong LP
Clin Nutr; 2020 Sep; 39(9):2751-2758. PubMed ID: 31839432
[TBL] [Abstract][Full Text] [Related]
26. Multivariate analysis of prognostic factors in patients with lip squamous cell carcinoma after surgery.
Cheng H; Xu JH; He JQ; Yang XY; Shen XN; Xu XL
World J Surg Oncol; 2024 Jan; 22(1):35. PubMed ID: 38279138
[TBL] [Abstract][Full Text] [Related]
27. Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced hypopharyngeal and laryngeal squamous cell carcinoma.
Peng J; Luo G; Yu Y; Ning K; Liu X
Cancer Immunol Immunother; 2024 Feb; 73(3):54. PubMed ID: 38358522
[TBL] [Abstract][Full Text] [Related]
28. Association Between Alcohol Dehydrogenase Polymorphisms and the Recurrence of Laryngeal Carcinoma.
Huang HY; Lau HC; Ji MY; Hsueh CY; Zhang M
Laryngoscope; 2022 Nov; 132(11):2169-2176. PubMed ID: 35218021
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: Outcome prediction after one cycle induction chemotherapy by a score based on clinical evaluation, computed tomography-based volumetry and
Wichmann G; Krüger A; Boehm A; Kolb M; Hofer M; Fischer M; Müller S; Purz S; Stumpp P; Sabri O; Dietz A; Kluge R
Eur J Cancer; 2017 Feb; 72():144-155. PubMed ID: 28033526
[TBL] [Abstract][Full Text] [Related]
30. Induction chemotherapy-based organ-preservation protocol improve the function preservation compared with immediate total laryngectomy for locally advanced hypopharyngeal cancer-Results of a matched-pair analysis.
Yang Y; Feng L; Zhong Q; Zhang Y; Huang Z; Zhang S; Li S; Gao J; Hou L; Ma H; He S; Shi Q; Lian M; Zhao Y; Shen X; Chen J; Wang L; Li H; Chen S; Xu J; Wang R; Fang J
Cancer Med; 2023 Aug; 12(16):17078-17086. PubMed ID: 37466348
[TBL] [Abstract][Full Text] [Related]
31. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation.
Ock CY; Keam B; Kim TM; Han DH; Won TB; Lee SH; Hah JH; Kwon TK; Kim DW; Kim DY; Rhee CS; Wu HG; Sung MW; Heo DS
Korean J Intern Med; 2016 May; 31(3):570-8. PubMed ID: 26976150
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma Patients.
Zhang D; Tang D; Heng Y; Zhu XK; Zhou L; Tao L; Lu LM
Laryngoscope; 2021 Apr; 131(4):E1249-E1255. PubMed ID: 33107987
[TBL] [Abstract][Full Text] [Related]
33. The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Zeng YY; Xiang ZZ; He T; Liu F; Shao BF; Yan RN; Ma JC; Wang XR; Liu L
Oral Oncol; 2020 Dec; 111():104924. PubMed ID: 32736209
[TBL] [Abstract][Full Text] [Related]
34. Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01).
Lee YG; Kang EJ; Keam B; Choi JH; Kim JS; Park KU; Lee KE; Kim HJ; Lee KW; Kim MK; Ahn HK; Shin SH; Kim HR; Kim SB; Yun HJ
Cancer Res Treat; 2022 Jan; 54(1):109-117. PubMed ID: 33940788
[TBL] [Abstract][Full Text] [Related]
35. [Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].
Li ZD; Lu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Dec; 53(12):918-924. PubMed ID: 30585004
[No Abstract] [Full Text] [Related]
36. The Prognostic Value of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio in Patients With Laryngeal Squamous Cell Carcinoma.
Cai H; Zhang ZH; Zhou YJ; Liu J; Chen HQ; Lin RY
Ear Nose Throat J; 2021 Dec; 100(10):731-736. PubMed ID: 32380854
[TBL] [Abstract][Full Text] [Related]
37. Transoral laser microsurgery for locally advanced (T3-T4a) supraglottic squamous cell carcinoma: Sixteen years of experience.
Vilaseca I; Blanch JL; Berenguer J; Grau JJ; Verger E; Muxí Á; Bernal-Sprekelsen M
Head Neck; 2016 Jul; 38(7):1050-7. PubMed ID: 26872432
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors.
Bozec A; Benezery K; Ettaiche M; Chamorey E; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Guigay J; Sudaka A; Demard F; Santini J; Peyrade F
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3299-306. PubMed ID: 26858198
[TBL] [Abstract][Full Text] [Related]
39. Nomograms predicting prognosis for locally advanced hypopharyngeal squamous cell carcinoma.
Yang H; Zeng M; Cao S; Jin L
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3041-3052. PubMed ID: 34648051
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III-IV lung squamous cell carcinoma.
Song J; Tian J; Zhang L; Qu X; Qian W; Zheng B; Zhang L; Zhao J; Niu M; Zhou M; Cui L; Liu Y; Zhao M
Eur Radiol; 2019 May; 29(5):2388-2398. PubMed ID: 30643941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
